Johnson & Johnson Shares Sold by Central Securities Corp

Got story updates? Submit your updates here. ›

Central Securities Corp, an institutional investor, decreased its position in Johnson & Johnson (NYSE:JNJ) by 11.1% during the third quarter. The firm now holds 80,000 shares of the company's stock, valued at $14.8 million, making it the 26th largest holding in its investment portfolio.

Why it matters

Johnson & Johnson is one of the world's largest and most well-known healthcare companies, with a diverse portfolio spanning pharmaceuticals, medical devices, and consumer products. Changes in ownership by major institutional investors can provide insights into market sentiment and expectations around the company's performance.

The details

Central Securities Corp sold 10,000 shares of Johnson & Johnson stock during the third quarter, reducing its total position to 80,000 shares. The firm's holdings in JNJ now make up approximately 1.2% of its overall investment portfolio. Several other large investors have also bought and sold shares of Johnson & Johnson in recent quarters, with some increasing their positions and others, like Central Securities, decreasing their stakes.

• Central Securities Corp reported its reduced position in Johnson & Johnson during the third quarter of 2026.